239 related articles for article (PubMed ID: 37027168)
21. Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
Hatzoglou V; Oh JH; Buck O; Lin X; Lee M; Shukla-Dave A; Young RJ; Peck KK; Vachha B; Holodny AI; Grommes C
J Neurooncol; 2018 Nov; 140(2):351-358. PubMed ID: 30073640
[TBL] [Abstract][Full Text] [Related]
22. Systemic inflammatory biomarkers in primary central nervous system lymphoma versus high-grade glioma: exploratory, comparative and correlative analysis.
Gupta T; Nayak P; Baviskar Y; Gupta M; Moiyadi A; Epari S; Janu A; Purandare N; Rangarajan V; Bagal B; Chatterjee A; Sastri GJ
CNS Oncol; 2022 Jun; 11(2):CNS83. PubMed ID: 35373582
[TBL] [Abstract][Full Text] [Related]
23. What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
Inoue A; Matsumoto S; Ohnishi T; Miyazaki Y; Kinnami S; Kanno K; Honda T; Kurata M; Taniwaki M; Kusakabe K; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Kunieda T
World Neurosurg; 2023 Apr; 172():e517-e523. PubMed ID: 36690204
[TBL] [Abstract][Full Text] [Related]
24. Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.
Chen T; Liu Y; Wang Y; Chang Q; Wu J; Wang Z; Geng D; Yu JT; Li Y; Li XQ; Chen H; Zhuang D; Li J; Wang B; Jiang T; Lyu L; Song Y; Qiu X; Li W; Lin S; Zhang X; Lu D; Lei J; Chen Y; Mao Y
J Hematol Oncol; 2022 Sep; 15(1):136. PubMed ID: 36176002
[TBL] [Abstract][Full Text] [Related]
25. Primary central nervous system lymphoma: an update.
Soussain C; Hoang-Xuan K
Curr Opin Oncol; 2009 Nov; 21(6):550-8. PubMed ID: 19684518
[TBL] [Abstract][Full Text] [Related]
26. Whether surgical resection or biopsy makes difference in single lesion primary central nervous system lymphoma: a single center retrospective cohort study.
Cheng X; Chen H; Sun C; Zhang B; Zhang J; Wang Y
BMC Neurol; 2022 Nov; 22(1):411. PubMed ID: 36333683
[TBL] [Abstract][Full Text] [Related]
27. A case report of primary central nervous system lymphoma.
Zeng X; Lu X; Li X; Peng L; Chen L
J Int Med Res; 2020 Jul; 48(7):300060520937839. PubMed ID: 32660288
[TBL] [Abstract][Full Text] [Related]
28. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
You SH; Yun TJ; Choi HJ; Yoo RE; Kang KM; Choi SH; Kim JH; Sohn CH
Eur Radiol; 2018 Sep; 28(9):3801-3810. PubMed ID: 29619520
[TBL] [Abstract][Full Text] [Related]
29. Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Barajas RF; Politi LS; Anzalone N; Schöder H; Fox CP; Boxerman JL; Kaufmann TJ; Quarles CC; Ellingson BM; Auer D; Andronesi OC; Ferreri AJM; Mrugala MM; Grommes C; Neuwelt EA; Ambady P; Rubenstein JL; Illerhaus G; Nagane M; Batchelor TT; Hu LS
Neuro Oncol; 2021 Jul; 23(7):1056-1071. PubMed ID: 33560416
[TBL] [Abstract][Full Text] [Related]
30. A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy.
Biswas A; Adhikari N; Bakhshi S; Gopinathan VR; Sharma MC
Pediatr Neurosurg; 2019; 54(1):57-65. PubMed ID: 30669145
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory Demyelinating Lesions: True Sentinel Lesion or Immune-Mediated Response to Lymphoma?
Qiu T; Chanchotisatien A; Qin Z; Wu J; Chu S
World Neurosurg; 2021 Jan; 145():172-177. PubMed ID: 32949800
[TBL] [Abstract][Full Text] [Related]
32. Balanced transformer: efficient classification of glioblastoma and primary central nervous system lymphoma.
Wang S; Wu J; Chen M; Huang S; Huang Q
Phys Med Biol; 2024 Feb; 69(4):. PubMed ID: 38232389
[No Abstract] [Full Text] [Related]
33. Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.
Nguyen AV; Blears EE; Ross E; Lall RR; Ortega-Barnett J
Neurosurg Focus; 2018 Nov; 45(5):E5. PubMed ID: 30453459
[TBL] [Abstract][Full Text] [Related]
34. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
35. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
[TBL] [Abstract][Full Text] [Related]
36. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
[TBL] [Abstract][Full Text] [Related]
37. Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma.
Sun C; Han J; Lin Y; Qi X; Li C; Liu J; Qiu F
Front Immunol; 2022; 13():986473. PubMed ID: 36059526
[TBL] [Abstract][Full Text] [Related]
38. Cytoreductive Surgery for Primary Central Nervous System Lymphoma: Is it time to consider extent of resection?
Singhal S; Antoniou E; Kwan E; Gregory G; Lai LT
J Clin Neurosci; 2022 Dec; 106():110-116. PubMed ID: 36274297
[TBL] [Abstract][Full Text] [Related]
39. Recurrent Epstein-Barr Virus-positive (EBV+) Primary Central Nervous System Lymphoma (PCNSL) in a Patient with Clinical Features of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).
Nagano M; Ayaki T; Koita N; Kitano T; Nishikori M; Goda N; Minamiguchi S; Ikeda A; Takaori-Kondo A; Takahashi R
Intern Med; 2019; 58(6):849-854. PubMed ID: 30880301
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological characteristics of primary central nervous system lymphoma with low 18F-fludeoxyglucose uptake on brain positron emission tomography.
Kim HO; Kim JS; Kim SO; Chae SY; Oh SJ; Seo M; Lee SH; Oh JS; Ryu JS; Huh JR; Kim JH
Medicine (Baltimore); 2020 May; 99(20):e20140. PubMed ID: 32443328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]